Occidental Asset Management, LLC Gilead Sciences, Inc. Transaction History

Occidental Asset Management, LLC

$616 Million
Q3 2024

A detailed history of Occidental Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Occidental Asset Management, LLC holds 34,636 shares of GILD stock, worth $3.18 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

34,636

Previous 31,676 9.34%

Holding current value

$3.18 Million

Previous $2.17 Million 33.59%

% of portfolio

0.47%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$66.59 - $83.99 $197,106 - $248,610	2,960 Added 9.34%	34,636 $2.9 Million
Q2 2024 Jul 15, 2024	BUY	$63.15 - $72.88 $195,828 - $226,000	3,101 Added 10.85%	31,676 $2.17 Million
Q1 2024 Apr 16, 2024	BUY	$71.58 - $87.29 $2.05 Million - $2.49 Million	28,575 New	28,575 $2.09 Million
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $1.09 Million - $1.24 Million	-18,095 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$56.65 - $64.55 $84,238 - $95,985	1,487 Added 8.95%	18,095 $1.05 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $21,983 - $27,640	354 Added 2.18%	16,608 $1.05 Million
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $36,242 - $42,084	501 Added 3.18%	16,254 $1.25 Million
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $177,556 - $227,423	2,835 Added 21.95%	15,753 $1.18 Million
Q4 2019 Jan 16, 2020	BUY	$61.62 - $67.78 $26,434 - $29,077	429 Added 3.44%	12,918 $839,000
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $116,268 - $128,340	1,860 Added 17.5%	12,489 $792,000
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $133,453 - $149,652	2,157 Added 25.46%	10,629 $718,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $108,301 - $121,326	1,732 Added 25.7%	8,472 $551,000
Q4 2018 Mar 19, 2019	BUY	$60.54 - $79.0 $27,848 - $36,340	460 Added 7.32%	6,740 $422,000
Q3 2018 Mar 19, 2019	BUY	$71.28 - $78.92 $20,599 - $22,807	289 Added 4.82%	6,280 $485,000
Q2 2018 Mar 19, 2019	BUY	$64.88 - $75.68 $13,105 - $15,287	202 Added 3.49%	5,991 $424,000
Q1 2018 Mar 20, 2019	SELL	$72.84 - $88.8 $2,913 - $3,552	-40 Reduced 0.69%	5,789 $436,000
Q4 2017 Mar 19, 2019	BUY	$71.15 - $83.52 $16,791 - $19,710	236 Added 4.22%	5,829 $418,000
Q3 2017 Mar 19, 2019	BUY	$72.11 - $85.47 $10,528 - $12,478	146 Added 2.68%	5,593 $453,000
Q2 2017 Mar 19, 2019	BUY	N/A	137 Added 2.58%	5,447 $386,000
Q1 2017 Mar 19, 2019	BUY	N/A	522 Added 10.9%	5,310 $361,000
Q4 2016 May 15, 2019	BUY	N/A	4,788	4,788 $343,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.

Account

Occidental Asset Management, LLC Gilead Sciences, Inc. Transaction History